Cathay Total Revenue from 2010 to 2024

688065 Stock   42.02  0.48  1.13%   
Cathay Biotech's Total Revenue is increasing over the years with slightly volatile fluctuation. Overall, Total Revenue is expected to go to about 2.3 B this year. Total Revenue is the total amount of income generated by the sale of goods or services related to Cathay Biotech's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
2.1 B
Current Value
2.3 B
Quarterly Volatility
229.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cathay Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cathay Biotech's main balance sheet or income statement drivers, such as Tax Provision of 56.8 M, Net Interest Income of 134.7 M or Interest Income of 156.9 M, as well as many indicators such as . Cathay financial statements analysis is a perfect complement when working with Cathay Biotech Valuation or Volatility modules.
  
This module can also supplement various Cathay Biotech Technical models . Check out the analysis of Cathay Biotech Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.